Pathophysiological relevance of the cardiac β2-adrenergic receptor and its potential as a therapeutic target to improve cardiac function

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 39-47

  Pérez Schindler, Joaquín ^a   Philp, Andrew ^b   Hernandez Cascales, Jesús ^c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

Beta adrenoceptors; Cardiac apoptosis; Cardiac arrhythmias; Cardiac contractility; Cardiac metabolism

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; ISOPRENALINE; SALBUTAMOL; TERBUTALINE;

CELL SURVIVAL; DRUG POTENCY; DRUG TARGETING; HEART ARRHYTHMIA; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART PROTECTION; HEART STIMULATION; HUMAN; INOTROPISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

ANIMALS; ARRHYTHMIAS, CARDIAC; HEART; HUMANS; MOLECULAR TARGETED THERAPY; MYOCARDIUM; MYOCYTES, CARDIAC; RECEPTORS, ADRENERGIC, BETA-2;

EID: 84871926826     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.001     Document Type: Review

References (102)

1. M.J. Abramson, J. Walters, and E.H. Walters Adverse effects of beta-agonists: are they clinically relevant? Am. J. Respir. Med. 2 2003 287 297 (Pubitemid 37045674)
2. I. Ahmet, M. Krawczyk, W. Zhu, A.Y. Woo, C. Morrell, S. Poosala, R.P. Xiao, E.G. Lakatta, and M.I. Talan Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction J. Pharmacol. Exp. Ther. 325 2008 491 499 (Pubitemid 351574789)
3. I. Ahmet, E.G. Lakatta, and M.I. Talan Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy Heart Failure Rev. 10 2005 289 296
4. A. Al-Hillawi, R. Hayward, and N.M. Johnson Incidence of cardiac arrhythmias in patients taking slow release salbutamol and slow release terbutaline for asthma Br. Med. J. 288 1984 367 (Pubitemid 14113685)
5. R.A. Altschuld, and G.E. Billman Beta(2)-Adrenoceptors and ventricular fibrillation Pharmacol. Ther. 88 2000 1 14
6. H. Ardehali, H.N. Sabbah, M.A. Burke, S. Sarma, P.P. Liu, J.G. Cleland, A. Maggioni, G.C. Fonarow, E.D. Abel, U. Campia, and M. Gheorghiade Targeting myocardial substrate metabolism in heart failure: potential for new therapies Eur. J. Heart Failure 14 2012 120 129
7. J.G. Baker The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors Br. J. Pharmacol. 144 2005 317 322 (Pubitemid 40313677)
8. S. Bartel, E.G. Krause, G. Wallukat, and P. Karczewski New insights into beta2-adrenoceptor signaling in the adult rat heart Cardiovasc. Res. 57 2003 694 703 (Pubitemid 36254863)
9. M. Baruscotti, A. Barbuti, and A. Bucchi The cardiac pacemaker current J. Mol. Cell. Cardiol. 48 2010 55 64
10. E. Bassiakou, T. Xanthos, E. Koudouna, S. Goulas, V. Prapa, D. Papadimitriou, G. Rokas, and L. Papadimitriou Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation Am. J. Emerg. Med. 26 2008 578 584 (Pubitemid 351755010)
11. A.T. Bender, and J.A. Beavo Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use Pharmacol. Rev. 58 2006 488 520 (Pubitemid 44394910)
12. G.E. Billman, L.C. Castillo, J. Hensley, C.M. Hohl, and R.A. Altschuld Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death Circulation 96 1997 1914 1922 (Pubitemid 27400753)
13. E.J. Birks, P.D. Tansley, J. Hardy, R.S. George, C.T. Bowles, M. Burke, N.R. Banner, A. Khaghani, and M.H. Yacoub Left ventricular assist device and drug therapy for the reversal of heart failure N. Engl. J. Med. 355 2006 1873 1884 (Pubitemid 44664645)
14. N.H. Bishopric, P. Andreka, T. Slepak, and K.A. Webster Molecular mechanisms of apoptosis in the cardiac myocyte Curr. Opin. Pharmacol. 1 2001 141 150 (Pubitemid 33586404)
15. D.C. Boer, J.W. Bassani, and R.A. Bassani Functional antagonism of beta-adrenoceptor subtypes in the catecholamine-induced automatism in rat myocardium Br. J. Pharmacol. 162 2011 1314 1325
16. M. Bohm, B. Pieske, P. Schnabel, R. Schwinger, B. Kemkes, W.P. Klövekorn, and E. Erdmann Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation J. Cardiovasc. Pharmacol. 14 1989 549 559 (Pubitemid 19232764)
17. M. Bohm, C. Schulz, R.H. Schwinger, and E. Erdmann Positive inotropic effects due to partial agonistic activity of the beta-adrenoceptor antagonist celiprolol following amplification of cAMP formation in failing human myocardium J. Cardiovasc. Pharmacol. 20 1992 479 489
18. O.E. Brodde, H. Bruck, and K. Leineweber Cardiac adrenoceptors: physiological and pathophysiological relevance J. Pharmacol. Sci. 100 2006 323 337 (Pubitemid 44609527)
19. D.A. Brown, and W.E. Cascio 'Leaky' ryanodine receptors and sudden cardiac death Cardiovasc. Res. 84 2009 343 344
20. G. Cammarata, M.H. Weil, S. Sun, W. Tang, J. Wang, and L. Huang Beta1-adrenergic blockade during cardiopulmonary resuscitation improves survival Crit. Care Med. 32 2004 S440 S443
21. C. Canto, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, J. Milne, P.J. Elliott, P. Puigserver, and J. Auwerx AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
22. M.D. Carceles, T. Fuentes, V. Aroca, J. Lopez, and J. Hernandez Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium Clin. Ther. 29 2007 1718 1724 (Pubitemid 47494545)
23. M. Cazzola, F. Imperatore, A. Salzillo, F. Di Perna, F. Calderaro, A. Imperatore, and M.G. Matera Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia Chest 114 1998 411 415 (Pubitemid 28387516)
24. E. Cerbai, I. Masini, and A. Mugelli Electrophysiological characterization of cardiac beta 2-adrenoceptors in sheep Purkinje fibers J. Mol. Cell. Cardiol. 22 1990 859 870 (Pubitemid 20281898)
25. E. Cerbai, R. Pino, M.L. Rodriguez, and A. Mugelli Modulation of the pacemaker current If by beta-adrenoceptor subtypes in ventricular myocytes isolated from hypertensive and normotensive rats Cardiovasc. Res. 42 1999 121 129 (Pubitemid 29167077)
26. S. Chakraborti, S. Das, P. Kar, B. Ghosh, K. Samanta, S. Kolley, S. Ghosh, S. Roy, and T. Chakraborti Calcium signaling phenomena in heart diseases: a perspective Mol. Cell. Biochem. 298 2007 1 40 (Pubitemid 46605281)
27. F. Charpentier, and M.R. Rosen Beta-adrenergic regulation of action potentials and automaticity in young and adult canine purkinje fibers Am. J. Physiol. 266 1994 H2310 H2319
28. A. Chesley, M.S. Lundberg, T. Asai, R.P. Xiao, S. Ohtani, E.G. Lakatta, and M.T. Crow The beta (2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase Circ. Res. 87 2000 1172 1179
29. J. Chinsomboon, J. Ruas, R.K. Gupta, R. Thom, J. Shoag, G.C. Rowe, N. Sawada, S. Raghuram, and Z. Arany The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle Proc. Nat. Acad. Sci. USA 106 2009 21401 21406
30. CIBIS Investigators and Committees A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS) Circulation 90 1994 1765 1773
31. L.P. Collis, S. Srivastava, W.A. Coetzee, and M. Artman Beta2-Adrenergic receptor agonists stimulate L-type calcium current independent of PKA in newborn rabbit ventricular myocytes Am. J. Physiol. Heart Circ. Physiol. 293 2007 H2826 H2835
32. C. Communal, K. Singh, D.B. Sawyer, and W.S. Colucci Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein Circulation 100 1999 2210 2216
33. P. Dorian Antiarrhythmic action of beta-blockers: potential mechanisms J. Cardiovasc. Pharmacol. Ther. 10 2005 S15 S22
34. V. Duronio The life of a cell: apoptosis regulation by the PI3K/PKB pathway Biochem. J. 415 2008 333 344
35. G.M. Felker, R.L. Benza, A.B. Chandler, J.D. Leimberger, M.S. Cuffe, R.M. Califf, M. Gheorghiade, and C.M. O'Connor OPTIME-CHF Investigators. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study J. Am. Coll. Cardiol. 41 2003 997 1003 (Pubitemid 36315544)
36. M. Freyss-Beguin, G. Griffaton, P. Lechat, D. Picken, M.C. Quennedey, B. Rouot, and J. Schwartz Comparison of the chronotropic effect and the cyclic AMP accumulation induced by beta 2-agonists in rat heart cell culture Br. J. Pharmacol. 78 1983 717 723 (Pubitemid 13111271)
37. T. Fujita, and Y. Ishikawa Apoptosis in heart failure - the role of the beta-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes Circ. J. 75 2011 1811 1818
38. Gonzalez-Muñoz, C., Fuente, T., Cordero-Ariaz, B., Hernández-Cascales, J., 2008. Cyclic nucleotide phosphodiesterase (PDE3 and PDE4) limit inotropy and cAMP production induced by the β2- adrenoceptors (β2-AR), salbutamol, in rat ventricular myocardium.; Available at: 〈www.pa2online.org/abstract/abstract.jsp?abid=28966〉
39. C. Gonzalez-Muñoz, T. Fuente, and J. Hernandez-Cascales Phosphodiesterases inhibition unmask a positive inotropic effect mediated by beta2-adrenoceptors in rat ventricular myocardium Eur. J. Pharmacol. 607 2009 151 155
40. C. Gonzalez-Muñoz, T. Fuente, S. Medin-Aguerre, and J. Hernandez-Cascales The increase in rat ventricular automaticity induced by salbutamol is mediated through beta(1)- but not beta(2)-adrenoceptors: role of phosphodiesterases Life Sci. 88 2011 1095 1101
41. alpha) proteins increases arrhythmogenic effects of beta-adrenergic stimulation in the heart J. Mol. Cell. Cardiol. 30 1998 1917 1928 (Pubitemid 28495318)
42. D.G. Hardie, F.A. Ross, and S.A. Hawley AMPK: a nutrient and energy sensor that maintains energy homeostasis Nat. Rev. Mol. Cell Biol. 13 2012 251 262
43. Y. Hayashi, K. Sumikawa, T. Kamibayashi, A. Yamatodani, T. Mammoto, M. Kuro, and I. Yoshiya Selective beta 1 and beta 2 adrenoceptor blockade on epinephrine-induced arrhythmias in halothane anaesthetized dogs Can. J. Anaesth. 39 1992 873 876
44. R.S. Hotchkiss, A. Strasser, J.E. McDunn, and P.E. Swanson Cell death N. Engl. J. Med. 361 2009 1570 1583
45. C. Huerta, S.F. Lanes, and L.A. Garcia-Rodriguez Respiratory medications and the risk of cardiac arrhythmias Epidemiology 16 2005 360 366 (Pubitemid 40586712)
46. S. Jager, C. Handschin, J. St-Pierre, and B.M. Spiegelman AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha Proc. Nat. Acad. Sci. USA 104 2007 12017 12022 (Pubitemid 47185622)
47. S.H. Jo, V. Leblais, P.H. Wang, M.T. Crow, and R.P. Xiao Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation Circ. Res. 91 2002 46 53 (Pubitemid 34778941)
48. W.B. Johnson, S. Katugampola, S. Able, C. Napier, and S.E. Harding Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig Life Sci. 90 2012 328 336
49. E.N. Juberg, K.P. Minneman, and P.W. Abel Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart Naunyn Schmiedeberg's Arch. Pharmacol. 330 1985 193 202 (Pubitemid 15003579)
50. A. Khoynezhad, Z. Jalali, and A.J. Tortolani A synopsis of research in cardiac apoptosis and its application to congestive heart failure Tex. Heart Inst. J. 34 2007 352 359 (Pubitemid 350057579)
51. H. Kikkawa, H. Kurose, M. Isogaya, Y. Sato, and T. Nagao Differential contribution of two serine residues of wild type and constitutively active β2-adrenoceptors to the interaction with β2-selective agonists Br. J. Pharmacol. 121 1997 1059 1064 (Pubitemid 27303572)
52. S.C. Kolwicz, and R. Tian Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization? Trends Cardiovasc. Med. 19 2009 201 207
53. J.M. Kramer Balancing the benefits and risks of inhaled long-acting beta-agonists-the influence of values N. Engl. J. Med. 360 2009 1592 1595
54. R.N. Lemaitre, D.S. Siscovick, B.M. Psaty, R.M. Pearce, T.E. Raghunathan, E.A. Whitsel, S.A. Weinmann, G.D. Anderson, and D. Lin Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest Am. J. Med. 113 2002 711 716 (Pubitemid 36044695)
55. G. Leonardo, E. Cerbai, S. Casini, G. Giunti, M. Bonacchi, F. Battaglia, B. Fiorani, P.L. Stefano, G. Sani, and A. Mugelli Pharmacological modulation of the hyperpolarization-activated current I(f) in human atrial myocytes: focus on G protein-coupled receptors J. Mol. Cell. Cardiol. 38 2005 453 460 (Pubitemid 40331936)
56. J. Li, B. Yan, Z. Huo, Y. Liu, J. Xu, Y. Sun, Y. Liu, D. Liang, L. Peng, Y. Zhang, Z.N. Zhou, J. Shi, J. Cui, and Y.H. Chen Beta2- but not beta1-adrenoceptor activation modulates intracellular oxygen availability J. Physiol. 588 2010 2987 2998
57. S.J. Maarbjerg, L. Sylow, and E.A. Richter Current understanding of increased insulin sensitivity after exercise - emerging candidates Acta Physiol. (Oxf.) 202 2011 323 335
58. G.A. McPherson, P. Molenaar, and E. Malta The affinity and efficacy of naturally ocurring catecholamines at beta-adrenoceptor subtypes J. Pharm. Pharmacol. 37 1985 499 501 (Pubitemid 15042948)
59. Merit-HF Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF) Lancet 353 1999 2001 2007
60. M.S. Mitra, J.D. Schilling, X. Wang, P.Y. Jay, J.M. Huss, X. Su, and B.N. Finck Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor gamma coactivator 1alpha/estrogen related receptor axis J. Mol. Cell. Cardiol. 51 2011 120 128
61. S. Miura, Y. Kai, Y. Kamei, and O. Ezaki Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise Endocrinology 149 2008 4527 4533
62. S. Miura, K. Kawanaka, Y. Kai, M. Tamura, M. Goto, T. Shiuchi, Y. Minokoshi, and O. Ezaki An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation Endocrinology 148 2007 3441 3448 (Pubitemid 46997005)
63. J.E. Muller, P.G. Kaufmann, R.V. Luepker, L. Weisfeldt, P.C. Deedwania, and J.T. Willerson Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants Circulation 96 1997 3233 3239
64. S. Neubauer The failing heart - an engine out of fuel N. Engl. J. Med. 356 2007 1140 1151 (Pubitemid 46425598)
65. J. Nevzorova, T. Bengtsson, B.A. Evans, and R.J. Summers Characterization of the beta-adrenoceptor subtype involved in mediation of glucose transport in L6 cells Br. J. Pharmacol. 137 2002 9 18 (Pubitemid 34983459)
66. J. Nevzorova, B.A. Evans, T. Bengtsson, and R.J. Summers Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells Br. J. Pharmacol. 147 2006 446 454 (Pubitemid 43292287)
67. G.E. Newton, E.R. Azevedo, and J.D. Parker Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study Circulation 99 1999 2402 2407 (Pubitemid 29218235)
68. R.A. Ngala, J. O'Dowd, S.J. Wang, A. Agarwal, C. Stocker, M.A. Cawthorne, and J.R. Arch Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms Br. J. Pharmacol. 155 2008 395 406
69. G. Olsson, J. Wilkstrand, I. Warnold, C.V. Manger, D. McBoyle, J. Herlitz, A. Hjalmarson, and E.H. Sonneblick Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials Eur. Heart J. 13 1992 28 32
70. I.S. Patten, and Z. Arany PGC-1 coactivators in the cardiovascular system Trends Endocrinol. Metab. 23 2012 90 97
71. J. Perez-Schindler, A. Philp, K. Baar, and J. Hernandez-Cascales Regulation of contractility and metabolic signaling by the beta2-adrenergic receptor in rat ventricular muscle Life Sci. 88 2011 892 897
72. L.H. Philipson β-Agonists and metabolism J. Allergy Clin. Immunol. 110 2002 S313 S317
73. K. Pönicke, F. Gröner, and I. Heinroth-Hoffmann Agonist-specific activation of the β2/Gs-protein and β2-adrenoceptor/ Gi-protein patway in adult rat ventricular cardiomyocytes Br. J. Pharmacol. 147 2006 714 719
74. F. Rochais, A. Abi-Gerges, K. Horner, F. Lefebvre, D.M. Cooper, M. Conti, R. Fischmeister, and G. Vandecasteele A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes Circ. Res. 98 2006 1081 1088
75. F.J. Roux, B. Grandordy, and J.S. Douglas Functional and binding characteristics of long acting beta 2-agonists in lung and heart Am. J. Respir. Crit. Care 153 1996 1489 1495 (Pubitemid 26141330)
76. K. Sakamoto, and G.D. Holman Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic Am. J. Physiol. Endocrinol. Metab. 295 2008 E29 E37
77. R.F. Schafers, S. Adler, A. Daul, G. Zeitler, M. Vogelsang, H.R. Zerkowski, and O.E. Brodde Positive inotropic effects of the beta 2-adrenoceptor agonist terbutaline in the human heart: effects of long-term beta 1-adrenoceptor antagonist treatment J. Am. Coll. Cardiol. 23 1994 1224 1233 (Pubitemid 24117160)
78. R.H. Schwinger, M. Böhm, C. Schulz, U. Schmidt, U. Schmidt, B. Schmid, H. Dienemann, B. Reichart, and E. Erdmann Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues J. Pharmacol. Exp. Ther. 265 1993 346 357 (Pubitemid 23320981)
79. B.N. Singh Beta-adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview J. Cardiovasc. Pharmacol. Ther. 10 2005 S3 S14
80. G.K. Soppa, R.T. Smolenski, N. Latif, A.H. Yuen, A. Malik, J. Karbowska, Z. Kochan, C.M. Terracciano, and M.H. Yacoub Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle Am. J. Physiol. Heart Circ. Physiol. 288 2005 H1468 H1476
81. E.A. Sosunov, R.Z. Gainullin, N.S. Moise, S.F. Steinberg, P. Danilo, and M.R. Rosen Beta(1) and beta(2)-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias Cardiovasc. Res. 48 2000 211 219
82. W.O. Spitzer, S. Suissa, P. Ernst, R.I. Horwitz, B. Brian Habbick, D. Cockcroft, J.-F. Boivin, M. McNutt, S. Buist, and A.S. Rebuck The use of β-agonists and the risk of death and near death from asthma N. Engl. J. Med. 326 1992 501 506
83. W.C. Stanley, F.A. Recchia, and G.D. Lopaschuk Myocardial substrate metabolism in the normal and failing heart Physiol. Rev. 85 2005 1093 1129 (Pubitemid 40894649)
84. S.F. Steinberg The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes Circ. Res. 85 1999 1101 1111
85. S. Suissa, B. Hemmelgarn, L. Blais, and P. Ernst Bronchodilators and acute cardiac death Am. J. Respir. Crit. Care Med. 154 1996 1598 1602 (Pubitemid 26424921)
86. M.I. Talan, I. Ahmet, R.P. Xiao, and E.G. Lakatta Beta AR agonists in treatment of chronic heart failure: long path to translation J. Mol. Cell. Cardiol. 51 2011 529 533
87. The Xamoterol in Severe Heart Failure Study Group Xamoterol in severe heart failure Lancet 336 1990 1 6
88. I. Verde, G. Vandecasteele, F. Lezoualc'h, and R. Fischmeister Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes Br. J. Pharmacol. 127 1999 65 74 (Pubitemid 29213233)
89. W. Wang, H. Zhang, H. Gao, H. Kubo, R.M. Berretta, X. Chen, and S.R. Houser {Beta}1-Adrenergic receptor activation induces mouse cardiac myocyte death through both L-type calcium channel-dependent and -independent pathways Am. J. Physiol. Heart Circ. Physiol. 299 2010 H322 H331
90. A.Y. Woo, and R.P. Xiao Beta-Adrenergic receptor subtype signaling in heart: from bench to bedside Acta Pharmacol. Sin. 33 2012 335 341
91. Z. Wu, X. Huang, Y. Feng, C. Handschin, Y. Feng, P.S. Gullicksen, O. Bare, M. Labow, B. Spiegelman, and S.C. Stevenson Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells Proc. Nat. Acad. Sci. USA 103 2006 14379 14384 (Pubitemid 44484758)
92. R.P. Xiao, P. Avdonin, Y.Y. Zhou, H. Cheng, S.A. Akhter, T. Eschenhagen, R.J. Lefkowitz, W.J. Koch, and E.G. Lakatta Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes Circ. Res. 84 1999 43 52 (Pubitemid 29074879)
93. R.P. Xiao, X. Ji, and E.G. Lakatta Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes Mol. Pharmacol. 47 1995 322 329
94. S. Xydas, A.R. Kherani, J.S. Chang, S. Klotz, I. Hay, C.J. Mutrie, G.W. Moss, A. Gu, A.R. Schulman, D. Gao, D. Hu, E.X. Wu, C. Wei, M.C. Oz, and J. Wang Beta(2)-adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy J. Pharmacol. Exp. Ther. 317 2006 553 561
95. D.L. Yamamoto, D.S. Hutchinson, and T. Bengtsson Beta(2)-adrenergic activation increases glycogen synthesis in L6 skeletal muscle cells through a signalling pathway independent of cyclic AMP Diabetologia 50 2007 158 167 (Pubitemid 46035864)
96. H.R. Zerkowski, K. Ikezono, N. Rohm, J.C. Reidemeister, and O.E. Brodde Human myocardial beta-adrenoceptors: demonstration of both beta 1- and beta 2-adrenoceptors mediating contractile responses to beta-agonists on the isolated right atrium Naunyn Schmiedeberg's Arch. Pharmacol. 332 1986 142 147 (Pubitemid 16134501)
97. Zhang, W., Yano, N., Deng, M., Mao, Q., Shaw, S.K., Tseng, Y.T., 2011. Beta-adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades. PLoS One. Available at 〈www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0026581〉
98. M. Zheng, Q.D. Han, and R.P. Xiao Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance Acta Physiol. Sin. 56 2004 1 15
99. M. Zheng, W. Zhu, Q. Han, and R.P. Xiao Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling Pharmacol. Ther. 108 2005 257 268 (Pubitemid 41691867)
100. W. Zhu, X. Zeng, M. Zheng, and R.P. Xiao The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly Circ. Res. 97 2005 507 509 (Pubitemid 41361739)
101. W. Zhu, A.Y. Woo, D. Yang, H. Cheng, M.T. Crow, and R.P. Xiao Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis J. Biol. Chem. 282 2007 10833 10839 (Pubitemid 47093465)
102. W.,.Z. Zhu, M. Zheng, W.J. Koch, R.J. Lefkowitz, B.K. Kobilka, and R.P. Xiao Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes Proc. Nat. Acad. Sci. USA 98 2001 1607 1612 (Pubitemid 32165546)